http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104478973-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
filingDate | 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104478973-B |
titleOfInvention | It is a kind of to recrystallize the method for reducing spiramvcin impurity |
abstract | A kind of to recrystallize the method for reducing the mould impurity of spiral, step is:(1) it is potassium dihydrogen phosphate is soluble in water, it is then 2~3 with careless acid for adjusting pH value;(2) by the mixed solution obtained by solid-state spiramvcin input step (1), keeping temperature is 25~40 DEG C of stirring and dissolvings;(3) it is 12~15% sodium hydroxide solutions to mass concentration is added in step (2) gained spiramvcin solution, heat up 60~90min, and then keeping temperature is stirred crystallization at 50~65 DEG C;(4) wet-milling is centrifugally separating to obtain, wet-milling repeat step (1), (2), (3) operate, wet-milling drying is obtained again can obtain low impurity spiramvcin.This method is the dosage by changing potassium dihydrogen phosphate and oxalic acid, during spiramvcin finished product is then re-dissolved into potassium dihydrogen phosphate and oxalic acid solution, is recrystallized, and the relevant material in spiramvcin is further removed, and then improve product quality. |
priorityDate | 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.